Atjaunināt sīkdatņu piekrišanu

Assessment of Feigned Cognitive Impairment, Second Edition: A Neuropsychological Perspective 2nd edition [Hardback]

Edited by (private practice, United States)
  • Formāts: Hardback, 710 pages, height x width: 254x178 mm, weight: 1448 g
  • Sērija : Evidence-Based Practice in Neuropsychology
  • Izdošanas datums: 02-Jul-2021
  • Izdevniecība: Guilford Press
  • ISBN-10: 1462545556
  • ISBN-13: 9781462545551
  • Hardback
  • Cena: 144,45 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 710 pages, height x width: 254x178 mm, weight: 1448 g
  • Sērija : Evidence-Based Practice in Neuropsychology
  • Izdošanas datums: 02-Jul-2021
  • Izdevniecība: Guilford Press
  • ISBN-10: 1462545556
  • ISBN-13: 9781462545551
The go-to resource for clinical and forensic practice has now been significantly revised with 85% new material, reflecting the tremendous growth of the field. Leading authorities synthesize the state of the science on symptom feigning in cognitive testing and present evidence-based recommendations for distinguishing between credible and noncredible performance. A wide range of performance validity tests (PVTs) and symptom validity tests (SVTs) are critically reviewed and guidelines provided for applying them across differing cognitive domains and medical, neurological, and psychiatric conditions. The book also covers validity testing in forensic settings and with particular populations, such as ethnic and linguistic minority group members.

New to This Edition
*Numerous new authors, a greatly expanded range of topics, and the latest data throughout.
*"Clinical primer" chapter on how to select and interpret appropriate PVTs.
*Chapters on methods for validity testing in visual&;spatial, processing speed, and language domains and with cognitive screening instruments and personality inventories.
*Chapter on methods for interpreting multiple PVTs in combination.
*Chapters on additional populations (military personnel, children and adolescents) and clinical problems (dementia, somatoform/conversion disorder).
*Chapters on research methods for validating PVTs, base rates of feigned mild traumatic brain injury, and more.

Recenzijas

"Boone has delivered a single, invaluable resource for cutting-edge information about assessing feigned cognitive impairment. In the second edition of this essential resource, a dream team of contributors survey the literature in this burgeoning field. The 29 chapters provide up-to-date, in-depth coverage of the research available to guide use of PVTs and SVTs with the broad range of populations that neuropsychologists assess. The second edition of this neuropsychology classic will be of interest to graduate students, interns, and fellows, as well as seasoned investigators and clinicians."--Yossef S. Ben-Porath, PhD, ABPP, Department of Psychological Sciences, Kent State University

"Boone's decades of clinical and forensic assessment experience, scholarly research, and test development are paying enormous dividends to the profession. With an outstanding cadre of chapter authors, Boone has brilliantly updated one of the most important volumes in forensic neuropsychology. This book is required reading for neuropsychologists new to forensic practice as well as for career professionals. It is an essential reference for those who want to conduct assessments and form opinions with a solid empirical basis. New and updated chapters provide a look in the rearview mirror at where the field has been, and a look to where we need to go in the future."--Joel E. Morgan, PhD, ABPP-CN, independent practice, Morristown, New Jersey

"Boone and her colleagues are at the forefront of detecting the exaggeration of symptoms and impairments for secondary gain, a growing area in neuropsychology over the last 30 years. This expanded second edition provides the latest research findings and assessment techniques to help practitioners carefully evaluate patients to identify those with legitimate impairments. This is a valuable book for clinician-scientists who conduct forensic evaluations and/or teach graduate neuropsychological assessment courses. It furthers the discussion of unique dilemmas and continuing legal reforms related to expert testimony and evidence law."--Paul M. Kaufmann, JD, PhD, ABPP, Senior Attorney, University of Texas System; private practice in forensic neuropsychology, San Antonio

"The first edition of this work has been a staple reference book for clinical neuropsychologists for more than a dozen years. The second edition is not merely an update, but reflects the reconceptualization and evolution of performance validity testing across the vast corpus of scientific literature that has accumulated in neuropsychology. This comprehensive guide covers research methodology, detection of feigned responses across multiple cognitive domains, and considerations for specific clinical populations. The volume is invaluable for any clinical neuropsychologist, as well as for graduate students and trainees learning the nuances of the assessment of test validity--the bedrock of accurate test interpretation--in clinical and forensic practice."--Bernice A. Marcopulos, PhD, ABPP, Department of Graduate Psychology, James Madison University; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine-The book continues its legacy of high-quality, pertinent reviews of the relevant literature and immediately useful summaries for clinical practice. This is the best source of information currently available on the assessment of feigned cognitive impairment in both its comprehensiveness and usefulness. It is a must-have book for practicing neuropsychologists. *****!--Doodys Review Service, 11/1/2021 "Boone has delivered a single, invaluable resource for cutting-edge information about assessing feigned cognitive impairment. In the second edition of this essential resource, a dream team of contributors survey the literature in this burgeoning field. The 29 chapters provide up-to-date, in-depth coverage of the research available to guide use of PVTs and SVTs with the broad range of populations that neuropsychologists assess. The second edition of this neuropsychology classic will be of interest to graduate students, interns, and fellows, as well as seasoned investigators and clinicians."--Yossef S. Ben-Porath, PhD, ABPP, Department of Psychological Sciences, Kent State University

"Boone's decades of clinical and forensic assessment experience, scholarly research, and test development are paying enormous dividends to the profession. With an outstanding cadre of chapter authors, Boone has brilliantly updated one of the most important volumes in forensic neuropsychology. This book is required reading for neuropsychologists new to forensic practice as well as for career professionals. It is an essential reference for those who want to conduct assessments and form opinions with a solid empirical basis. New and updated chapters provide a look in the rearview mirror at where the field has been, and a look to where we need to go in the future."--Joel E. Morgan, PhD, ABPP-CN, independent practice, Morristown, New Jersey

"Boone and her colleagues are at the forefront of detecting the exaggeration of symptoms and impairments for secondary gain, a growing area in neuropsychology over the last 30 years. This expanded second edition provides the latest research findings and assessment techniques to help practitioners carefully evaluate patients to identify those with legitimate impairments. This is a valuable book for clinician-scientists who conduct forensic evaluations and/or teach graduate neuropsychological assessment courses. It furthers the discussion of unique dilemmas and continuing legal reforms related to expert testimony and evidence law."--Paul M. Kaufmann, JD, PhD, ABPP, Senior Attorney, University of Texas System; private practice in forensic neuropsychology, San Antonio

"The first edition of this work has been a staple reference book for clinical neuropsychologists for more than a dozen years. The second edition is not merely an update, but reflects the reconceptualization and evolution of performance validity testing across the vast corpus of scientific literature that has accumulated in neuropsychology. This comprehensive guide covers research methodology, detection of feigned responses across multiple cognitive domains, and considerations for specific clinical populations. The volume is invaluable for any clinical neuropsychologist, as well as for graduate students and trainees learning the nuances of the assessment of test validity--the bedrock of accurate test interpretation--in clinical and forensic practice."--Bernice A. Marcopulos, PhD, ABPP, Department of Graduate Psychology, James Madison University; Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine-The book continues its legacy of high-quality, pertinent reviews of the relevant literature and immediately useful summaries for clinical practice. This is the best source of information currently available on the assessment of feigned cognitive impairment in both its comprehensiveness and usefulness. It is a must-have book for practicing neuropsychologists. *****!--Doodyās Review Service, 11/1/2021

PART I PERFORMANCE AND SYMPTOM VALIDITY TESTS
1 Clinician's Guide to Navigating Performance Validity Testing
3(8)
Maria Easter Cottingham
2 Design Methods in Neuropsychological Performance Validity, Symptom Validity, and Malingering Research
11(23)
Ryan W. Schroeder
Kyle Brauer Boone
Glenn J. Larrabee
3 Forced-Choice Performance Validity Tests
34(30)
Ryan W. Schroeder
Phillip K. Martin
4 Alternatives to Forced-Choice Performance Validity Tests
64(30)
Stephen R. Nitch
Alexis S. Rosen
Laurel A. Mattos
Scott Roye
David Glassmire
5 Intelligence Tests as Performance Validity Measures
94(17)
Natalie Sobel
Talin Babikian
Kyle Brauer Boone
6 Performance Validity Tests in Cognitive Screening Instruments and Computerized Assessment Tools
111(13)
Patrick Armistead-Jehle
Robert D. Shura
7 Embedded Performance Validity Scores in Standard Memory Tests
124(22)
Bradley N. Axelrod
Justin B. Miller
Jennifer Aileen LaBuda
8 Validity Indicators within Executive Function Measures: Use and Limits in Detection of Response Validity
146(29)
Nathaniel William Nelson
Catherine Lee
Jerry J. Sweet
9 Motor and Sensory Tests as Measures of Performance Validity
175(27)
Ginger Arnold
Kyle Brauer Boone
10 The Use of Visual-Spatial Performance Validity Tests in Detecting Noncredible Performance
202(16)
Douglas M. Whiteside
Lauren E. Piper
Michael Basso
Kyle Brauer Boone
11 Information Processing Speed Tests as Performance Validity Tests
218(30)
Laszlo Attila Erdodi
Jonathan D. Lichtenstein
12 Language Tests as Performance Validity Tests
248(16)
Phillip K. Martin
Ryan W. Schroeder
13 Effects of Premorbid Ability, Neuropsychological Impairment, and Invalid Test Performance on the Frequency of Low Scores
264(19)
Martin Rohling
Jennifer Langhinrichsen-Rohling
John E. Meyers
14 Interpretation of Data from Multiple Performance Validity Tests
283(24)
Jeremy J. Davis
15 Using the MMPI-2-RF as an Aid in the Detection of Noncredible Neurocognitive Presentations
307(18)
Maria Easter Cottingham
Kyle Brauer Boone
Hope E. Goldberg
Tara L. Victor
Michelle A. Zeller
Medina Baumgart
J. Brandon Birath
Matthew J. Wright
16 Utility of the Personality Assessment Inventory in Evaluating Symptom Validity in the Context of Neuropsychological Evaluation
325(16)
Owen Gaasedelen
Douglas M. Whiteside
Kyle Brauer Boone
PART II USE OF PERFORMANCE VALIDITY TESTS IN VARIOUS POPULATIONS
17 Base Rates of Feigned Mild Traumatic Brain Injury
341(15)
Kyle Brauer Boone
Pavel Litvin
Tara L. Victor
18 Noncredible Presentations in Neuropsychological Assessment of Pain- and Fatigue-Related Disorders: Clinical and Research Implications
356(31)
Julie A. Suhr
Andrew Bryant
19 The Impact of Psychotic, Depressive, Bipolar, Obsessive-Compulsive, and Anxiety Disorders on Performance Validity Test Results
387(46)
Hope E. Goldberg
J. Brandon Birath
20 Performance Validity in Somatoform/Conversion Disorders, Factitious Disorder, and Malingering: Do We Need a New Diagnostic Schema?
433(20)
Kyle Brauer Boone
21 Identification of Feigned Intellectual Disability
453(28)
Tara L. Victor
Kyle Brauer Boone
22 Performance Validity Testing in Patients with Dementia
481(23)
Kirsty E. Bortnik
Andy C. Dean
23 Performance Validity Tests in the Epilepsy Clinic
504(21)
Daniel Drane
David Williamson
Kelsey Hewitt
Taylor Jordan
24 Use of Performance Validity Tests and Symptom Validity Tests in Assessment of Specific Learning Disorders and Attention-Deficit/Hyperactivity Disorder
525(34)
Allyson G. Harrison
Grace J. Lee
Julie A. Suhr
25 Toxic Mold Syndrome and Multiple Chemical Sensitivity: The Continued Search for a Causal Link to Neuropsychological Functioning
559(19)
Robert J. McCaffrey
Julie K. Lynch
26 The Use of Performance Validity Tests in Ethnic-Minority and Non-English-Dominant Populations
578(31)
Xavier F. Salazar
Po H. Lu
Kyle Brauer Boone
27 Performance/Symptom Validity Test Use with Active Duty Service Members and Veterans
609(24)
Patrick Armistead-Jehle
Douglas B. Cooper
Heather Belanger
Jason R. Soble
Nathanial William Nelson
28 Validity Assessment in Pediatric Populations
633(23)
Alison M. Colbert
Emily C. Maxwell
Michael W. Kirkwood
29 Assessment of Feigned Cognitive Impairment in Criminal Forensic Neuropsychological Settings
656(33)
Robert L. Denney
Rachel L. Fazio
Index 689
Kyle Brauer Boone, PhD, ABPP, ABCN, has a private practice in Torrance, California, and is Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles. She has published six books and over 125 peer-reviewed research articles, including many in the area of development and validation of tests to detect feigned cognitive symptoms. She has also published two tests used to assess for performance validity on neuropsychological exams: the b Test and the Dot Counting Test. Dr. Boone served on the committee that developed the practice guidelines for clinical neuropsychology published by the American Academy of Clinical Neuropsychology in 2007, and she was an invited attendee of the 25-member consensus conference that developed the practice guidelines for the use of neurocognitive performance validity tests published by the American Academy of Clinical Neuropsychology in 2009 and updated in 2021. She is board certified through the American Board of Clinical Neuropsychology, is a Fellow of the American Psychological Association, and is the 2020 recipient of the Ralph M. Reitan Award for Clinical Excellence from the National Academy of Neuropsychology.